Fuiani, Aurora (2021) The Utility of Delta-9-Tetrahydrocannibinol Therapy in a Multiple Sclerosis Patient with a Neoplastic Brain Lesion. European Journal of Case Reports in Internal Medicine, 8 (5). pp. 1-4. ISSN ISSN: 2284-2594
|
Text
2188-Article Text-22194-1-10-20210430.pdf - Published Version Download (468kB) | Preview |
Abstract
Multiple sclerosis (MS) can sometimes cause uncommon pseudotumoural lesions that produce atypical symptoms, such as motor epileptic seizures which are often pharmacoresistant. In these cases, accurate diagnosis is essential for correct therapy, even if unconventional. We present the case of a brain tumour in a 40-year-old relapsing-remitting MS patient who presented with pharmacoresistant seizures which eventually responded to nabiximols. After various therapeutic approaches, delta-9-tetrahydrocannabinol therapy was introduced with good results. Spasticity improved, pain decreased and we observed a reduction in the number of daily seizures. It is possible that delta-9-tetrahydrocannabinol can enhance the efficacy of anti-epilepsy therapy.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Multiple sclerosis, delta-9-tetrahydrocannabinol, brain tumour, epileptic seizure |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 25 Jan 2022 15:30 |
| Last Modified: | 25 Jan 2022 15:30 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21256 |
Actions (login required)
 |
View Item |
